PlainRecalls
FDA Drug Low Class III Terminated

Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06

Reported: July 19, 2017 Initiated: June 22, 2017 #D-0974-2017

Product Description

Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06

Reason for Recall

Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.

Details

Units Affected
12480 bottles
Distribution
Nationwide in the USA
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 12480 bottles.
Why was this product recalled?
Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2017. Severity: Low. Recall number: D-0974-2017.